Search
United States District CourtNorthern District Of Colorado USA v Bruce Holder et al Second Superseding Indictment Filed August 19, 2019 Read the document.
Read More
United States District CourtNorthern District Of California, San Francisco Division USA v Lindsay Marie Clark Indictment21 U.S.C. §§ 331(c), 333(a)(2) – Receipt in interstate commerce of a drug that is misbranded, and a device that is adulterated and misbranded, and the delivery or proffered delivery thereof for pay or otherwise, with intent to defraud and mislead Filed April 1, 2021…
Read More
United States District CourtNorthern District of California, San Francisco Division USA v Lindsay Marie Clark and Lindsay Clark, M.D., Medical Corporation Sentencing Memo21 U.S.C. §§ 331(c), 333(a)(2) – Receipt in interstate commerce of a drug that is misbranded, and a device that is adulterated and misbranded, and the delivery or proffered delivery thereof for pay or otherwise, with intent to…
Read More
Almost 200 packages of fake Ozempic traveled from Austria to the U.K. via Germany. An 11th man was sentenced in a $52mm cough medicine counterfeiting scheme. Europol reports the seizure of medical products. Additional news about pill presses in Mexico and the U.S.
Read More
The leaders of the “Genesis II Church of Health and Healing” received a cumulative 34 years in prison. A NYC pharmacist pleaded guilty to fraud and money laundering after selling black market HIV drugs. Pill press operations busted in NYC and Rhode Island.
Read More
The FDA is cracking down on lax safety testing of raw drug ingredients. Major players in HIV drug and cough syrup counterfeiting schemes pleaded guilty in federal court.
Counterfeit Avastin in Pakistan blinded over 70 retinopathy patients.
CBP at JFK Airport intercepted 14 pairs of pill press dies. Additional news about illicit pill presses in five states.
Read More
Shabbir Imber Safdar, executive director of the Partnership for Safe Medicines, will participate in the upcoming United States Patent and Trademark Office Roundtable: Future strategies in anti-counterfeiting and anti-piracy.
Read More
USFDA is concerned that eight companies, including two pharmacies, are illegally marketing unapproved ophthalmic drug products that pose a heightened risk to users. Counterfeit pills make the DHS’ threat assessment list for 2024.
Read More
Data recently shared in the Morbidity and Mortality Weekly Report highlights a growing problem: Counterfeit pill availability is rising in the drug supply chain, but also the illicit drug market.
Read More
Running slides between conference sessions and during breaks is a great way to fit in a little extra information. Use these slides to teach your community about counterfeit medicines in the U.S.
Read More